| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032968A1 Compositions for lessening oxidative stress |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2003032753A1 Use of cystathionine |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | US20030078417 For protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents; for therapy of phospholipase mediated injury, injury due to oxidation, and inflammation |
| 04/24/2003 | US20030078304 Administering to animal or man of at least one type of xanthophyll in an amount inhibiting the expression of inflammatory cytokines and chemokines in animal or man |
| 04/24/2003 | US20030078299 Anti-cancer nitro- and thia-fatty acids |
| 04/24/2003 | US20030078274 Method of reducing neuronal injury or apoptosis |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078241 Treating effects of excessive reactive oxygen species |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2462713A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 04/24/2003 | CA2461758A1 Use of cystathionine |
| 04/23/2003 | EP1304114A1 Adsorbent for endocrine disruptors and foods and drinks containing the same |
| 04/23/2003 | EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/23/2003 | EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/23/2003 | EP1303517A1 Indoloquinazolinones |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 04/23/2003 | EP1303260A2 Linkage of agents using microparticles |
| 04/23/2003 | EP1185175B1 Method of increasing the content of flavonoids and phenolic substances in plants |
| 04/23/2003 | EP1045851B1 Substituted porphyrins |
| 04/23/2003 | EP0699072B1 Use of iron-binding polymers for the manufacture of a medicament for oral administration |
| 04/23/2003 | CN1413197A 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 04/23/2003 | CN1411809A Usage and composition of pyridine onium derivative for curing application |
| 04/23/2003 | CN1411808A N-acetyl-5,6-dimethoxytryptamine for preparing medicine resisting oxidation free radical |
| 04/23/2003 | CN1411800A Cosmetic composition and method |
| 04/22/2003 | US6551991 Recombinant proteins derived from HGF and MSP |
| 04/22/2003 | US6551989 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003030930A1 Human 3 relaxin |
| 04/17/2003 | WO2003030897A1 Pyrrolidinone derivatives |
| 04/17/2003 | WO2003030888A1 Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals |
| 04/17/2003 | WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | WO2001072752A3 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS |
| 04/17/2003 | US20030073732 Antiinflammatory agents |
| 04/17/2003 | US20030072804 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2463170A1 Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals |
| 04/17/2003 | CA2462892A1 Human 3 relaxin |
| 04/17/2003 | CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/16/2003 | EP1302115A1 Use of cystathionine |
| 04/16/2003 | EP1301515A1 Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
| 04/16/2003 | EP1301181A2 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds |
| 04/16/2003 | CN1410434A Pristimerin series dorivative possessing antioxidation and antitumour activity and its synthesis method |
| 04/16/2003 | CN1410111A 玫瑰花提取物及其应用 Rose extract and its application |
| 04/16/2003 | CN1410085A Ripening agent and eliminating agent for abnormal black balliary matter and its preparation method |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003028590A1 Rational drug therapy device and methods |
| 04/10/2003 | WO2002060423A3 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/10/2003 | WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments |
| 04/10/2003 | WO2002009678A3 Charged phospholipid compositions and methods for their use |
| 04/10/2003 | US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects |
| 04/10/2003 | US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 04/10/2003 | US20030069396 Neutralizing agent for toxin of microorganism belonging to the genus clostridium |
| 04/10/2003 | US20030069311 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity |
| 04/10/2003 | US20030069273 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 04/10/2003 | US20030069270 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxImic acid derivative |
| 04/10/2003 | US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 04/10/2003 | US20030068315 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/09/2003 | EP1300394A1 Method for the production of a water-dispersible formulation containing carotenoids |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299406A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 04/09/2003 | EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 04/09/2003 | EP1299380A1 Indole derivatives useful for the treatment of cns disorders |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299157A1 Composition and applicator for topical substance delivery |
| 04/09/2003 | EP1299125A1 Production, stabilisation and use of reduced forms of pharmaceutical compounds |
| 04/09/2003 | EP1299104A1 Tamper-resistant oral opioid agonist formulations |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409637A Skin-care agent, skin antiaging agent, whitening agent and external skin preparations |
| 04/09/2003 | CN1409626A Catechol oximes and their use in cosmetic and dermatological preparations |
| 04/09/2003 | CN1408427A Reduced type glutathione lozenge |
| 04/09/2003 | CN1104904C Natural tea for taking off the offect of drink and process for production thereof |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6544975 Mimetics that inhibit lipid peroxidation; for use in the treatment of diseases or disorders mediated by oxidative stress, such as asthma, inflammatory bowel disease, arthritis and vasculitis. |
| 04/08/2003 | US6544965 Compounds with an antioxidant activity, compositions useful as food integrators containing them and process for their preparation |
| 04/08/2003 | US6544964 Cyclodextrin derivatives in which at least one of the hydroxy groups has been methylated whilst the other hydroxy groups may be modified by methyl groups or other groups, for complexing lead ions. |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003026655A1 New formulations and use thereof |
| 04/03/2003 | WO2003026647A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 04/03/2003 | WO2003026634A1 Amines with antialcoholic agents |
| 04/03/2003 | US20030064430 Novel steroid-activated nuclear receptors and uses therefor |
| 04/03/2003 | US20030064114 For vasodilatation and inhibition of transplant rejection |
| 04/03/2003 | US20030064029 Use of a bioactive agent in manufacture of a medicament for pulmonary delivery whereby medicament comprises perforated microstructures which are aerosolized using an inhalation device to provide aerosolized medicament |
| 04/03/2003 | CA2461150A1 Amines with antialcoholic agents |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/02/2003 | EP1297849A1 Remedial agent for optic nerve disease and the like |
| 04/02/2003 | EP1297830A1 Use of alpha- or beta-amino acids, of the corresponding esters or of dipeptides of these amino acids with histidine derivatives in the prevention or treatment of tissue damage caused by a atmospheric ozone |
| 04/02/2003 | EP1296945A1 Sulfonamide derivatives |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |